Physician
Oncology
Dr. John F. Ensley, MD
|
|
Give Review
John Ensley works in the field of Oncology. He researched medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care He received 33 awards: "Top 100 Executives", "Whos Who in America 5th Year Consecutive Award", "Whos Who Among Executives and Professionals", "Biltmore Who's Who Edition of Who's Who Among Executives and Professionals", "Distinguished Professionals Online Registry Among Executives", "Distinguished Professionals Online", "Honorary Staff Member Detroit Medical Center", "Whos Who in America", "Who's Who Among Executives and Professionals", "Presidential Whos Who In America", "International Association of Business Leaders", "Strathmore's Who's Who in America", "The Global Directory of Who's Who Online", "Best Doctors in America, Emeritus Status", "Nominated, Whose Who in America", "Inventors Recognition Award", "Metropolitan Whos Who", "School of Medicine Teaching Award", "Whose Who in America", "Outstanding Teacher of the Year", "Selected one of top 25 Researchers for AACR Index", "Distinguished Alumni Award", "Best Doctors in America", "Distinguished Service Award - 25 Years", "Alpha Omega Alpha Honor Medical Society", "College Teaching Award", "Selected "Best Doctors in America"", "Recipient, Presidents Bonus Award", "Fellow", "Clinical Fellowship Award", "Deans Citation for perfect honor point average", "Scholarship Award" and "Teaching Fellowship Award". Doctor John F. Ensley, MD is a published physician. He published 26 publications, including: 'XRP6258-induced gene expression patterns in head and neck cancer carcinoma.'
Publications
- XRP6258-induced gene expression patterns in head and neck cancer carcinoma.
- Intratumoral delivery of docetaxel enhances antitumor activity of Ad-p53 in murine head and neck cancer xenograft model.
- Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
- BMS-275183-induced gene expression patterns in head and neck carcinoma.
- Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncol...
- Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck.
- Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
- An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.
- Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.
- Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
- Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.
- Correlation of histopathological variants, cellular DNA content, and clinical outcome in adenoid cystic carcinoma of the salivary glands.
- Pseudoaneuploid subpopulations detected in normal upper aerodigestive tract mucosa consistent with physiological apoptosis in normally differentiating squamous mucosa.
- Microsatellite alterations in african americans with head and neck cancer.
- Microsatellite analysis of serum DNA in patients with head and neck cancer.
- Cytochrome p450 and glutathione transferase expression in squamous cell cancer.
- Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a case report and review of the literature.
- Hormone-refractory prostate cancer responding to capecitabine.
- An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and...
- Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
- Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
- In vivo characteristics of HPV-immortalized and carcinogen transformed oral keratinocytes.
- Laminin-gamma2 overexpression in head-and-neck squamous cell carcinoma.
- Anticancer activity of docetaxel in murine salivary gland carcinoma.
- The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes.
Schools
Wayne State University
Wayne St University Affil Hospital
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Great West Healthcare-Cigna PPO
- Cofinity PPO
Awards
- Top 100 Executives
- Who’s Who in America 5th Year Consecutive Award
- Who’s Who Among Executives and Professionals
- Biltmore Who's Who Edition of Who's Who Among Executives and Professionals
- Distinguished Professionals Online Registry Among Executives
- Distinguished Professionals Online
- Honorary Staff Member Detroit Medical Center
- Who’s Who in America
- Who's Who Among Executives and Professionals
- Presidential Who’s Who In America
- International Association of Business Leaders
- Strathmore's Who's Who in America
- The Global Directory of Who's Who Online
- Best Doctors in America, Emeritus Status
- Nominated, Whose Who in America
- Inventors Recognition Award
- Metropolitan Who’s Who
- School of Medicine Teaching Award
- Whose Who in America
- Outstanding Teacher of the Year
- Selected one of top 25 Researchers for AACR Index
- Distinguished Alumni Award
- Best Doctors in America
- Distinguished Service Award - 25 Years
- Alpha Omega Alpha Honor Medical Society
- College Teaching Award
- Selected "Best Doctors in America"
- Recipient, President’s Bonus Award
- Fellow
- Clinical Fellowship Award
- Dean’s Citation for perfect honor point average
- Scholarship Award
- Teaching Fellowship Award
Education
-
Wayne State University School of Medicine -
Wayne State University
Drug Facts
| NPI NUMBER | 1326240573 | |
| NPPES Provider LastName | ENSLEY | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 98021 | |
| NPPES Provider State | WA | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 172.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 29.0 | |
| Percent Opioid Claims | 16.86 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326240573 |
| Last Name Of The Provider | ENSLEY |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Anthony F. Shields, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Elisabeth I. Heath, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Eudoro Coello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamad A. Younes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert A. Chapman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elaina M. Gartner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nazik Hammad, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ira S. Wollner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Randa Loutfi, MD
This Doctor is OpenDoctor Recommended.
|